Year Published
- 2008 (0)
- 2009 (0)
- 2010 (1) Apply 2010 filter
- 2011 (0)
- (-) Remove 2012 filter 2012
- 2013 (0)
- 2014 (1) Apply 2014 filter
- 2015 (3) Apply 2015 filter
- 2016 (3) Apply 2016 filter
- (-) Remove 2017 filter 2017
- 2018 (2) Apply 2018 filter
- 2019 (1) Apply 2019 filter
- 2020 (0)
- 2021 (1) Apply 2021 filter
Research Topics
Populations
Types of Research
- Data Analysis (4) Apply Data Analysis filter
- Literature Review (3) Apply Literature Review filter
- Portfolio Review (0)
- Research Brief (0)
Geography
- (-) Remove East Africa Region and Selected Countries filter East Africa Region and Selected Countries
- (-) Remove Global filter Global
- South Asia Region and Selected Countries (4) Apply South Asia Region and Selected Countries filter
- Southern Africa Region and Selected Countries (1) Apply Southern Africa Region and Selected Countries filter
- Sub-Saharan Africa (2) Apply Sub-Saharan Africa filter
- West Africa Region and Selected Countries (3) Apply West Africa Region and Selected Countries filter
Dataset
Current search
- (-) Remove East Africa Region and Selected Countries filter East Africa Region and Selected Countries
- (-) Remove 2017 filter 2017
- (-) Remove Aid & Other Development Finance filter Aid & Other Development Finance
- (-) Remove Finance & Investment filter Finance & Investment
- (-) Remove 2012 filter 2012
- (-) Remove Technology Adoption filter Technology Adoption
- (-) Remove Global filter Global
- (-) Remove Global & Regional Public Goods filter Global & Regional Public Goods
The share of private sector funding, relative to public sector funding, for drug, vaccine, and diagnostic research & development (R&D) differs considerably across diseases. Private sector investment in overall health R&D exceeds $150 billion annually, but is largely concentrated on non-communicable chronic diseases with only an estimated $5.9 billion focused on "global health", targeting diseases that primarily affect low and middle-income countries (LMICs). We examine the evidence for five specific disincentives to private sector global health R&D investment: scientific uncertainty, weak policy environments, limited revenues and market uncertainty, high fixed and sunk costs, and downstream rents from imperfect markets. Though all five may affect estimates of net returns from an investment decision, they are worth examining separately as each calls for a different intervention or remediation to change behavior.
Donor countries and multilateral organizations may pursue multiple goals with foreign aid, including supporting low-income country development for strategic/security purposes (national security, regional political stability) and for short-and long-term economic interests (market development and access, local and regional market stability). While the literature on the effectiveness of aid in supporting progress on different indicators of country development is inconclusive, donors are interested in evidence that aid funding is not permanent but rather contributes to a process by which recipient countries develop to a point that they are economically self-sufficient. In this report, we review the literature on measures of country self-sufficiency and descriptive evidence from illustrative case studies to explore conditions associated with transitions toward self-sufficiency in certain contexts.
In this report we analyze three waves nationally-representative household survey data from Kenya, Uganda, Tanzania, Nigeria, Pakistan, Bangladesh, India, and Indonesia to explore sociodemographic and economic factors associated with mobile money adoption, awareness, and use across countries and over time. Our findings indicate that to realize the potential of digital financial services to reach currently unbanked populations and increase financial inclusion, particular attention needs to be paid to barriers faced by women in accessing mobile money. While policies and interventions to promote education, employment, phone ownership, and having a bank account may broadly help to increase mobile money adoption and use, potentially bringing in currently unbanked populations, specific policies targeting women may be needed to close current gender gaps.
An ongoing stream of EPAR research considers how public good characteristics of different types of research and development (R&D) and the motivations of different providers of R&D funding affect the relative advantages of alternative funding sources. For this project, we seek to summarize the key public good characteristics of R&D investment for agriculture in general and for different subsets of crops, and hypothesize how these characteristics might be expected to affect public, private, or philanthropic funders’ investment decisions.
The concept of global public goods represents a framework for organizing and financing international cooperation in global health research and development (R&D). Advances in scientific and clinical knowledge produced by biomedical R&D can be considered public goods insofar as they can be used repeatedly (non-rival consumption) and it is difficult or costly to exclude non-payers from gaining access (non-excludable). This paper considers the public good characteristics of biomedical R&D in global health and describes the theoretical and observed factors in the allocation R&D funding by public, private, and philanthropic sources.
This brief explores how two datasets – The Tanzania National Panel Survey (TZNPS) and the TNS-Research International Farmer Focus (FF) – predict the determinants of inorganic fertilizer use among smallholder farmers in Tanzania by using regression analysis. The (TZNPS) was implemented by the Tanzania National Bureau of Statistics, with support from the World Bank Living Standards Measurement Study – Integrated Surveys on Agriculture (LSMS-ISA) team and includes extensive information on crop productivity and input use. The FF survey was funded by the Bill and Melinda Gates Foundation and implemented by TNS Research International and focuses on the on the behaviors and attitudes of smallholder farmers in Tanzania. The two datasets produce relatively comparable results for the primary predictors of inorganic fertilizer use: agricultural extension and whether or not a household grows cash crops. However, other factors influencing input use produce results that vary in magnitude and direction of the effect across the two datasets. Distinct survey instrument designs make it difficult to test the robustness of the models on input use other than inorganic fertilizer. This brief uses data inorganic fertilizer use, rather than adoption per se. The TZNPS did not ask households how recently they began using a certain product and although the FF survey asked respondents how many new inputs were tried in the past four planting seasons, they did not ask specifically about inorganic fertilizer.